Catalent Stock Price. Everything You Need To Know About The Catalent Stock!
Catalent, Inc. is a holding company that specializes in providing delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. The company’s headquarters are located in Somerset, New Jersey and it currently employs 19,000 full-time staff members. Catalent, Inc. went public on July 31st, 2014.
The company is organized into four segments: Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. The Biologics segment offers development and manufacturing services for various products, including protein, plasmid DNA mRNA, cell therapy, viral vaccines, and viral-based gene therapies. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules, as well as large-scale manufacturing of oral solid dose forms. The Oral and Specialty Delivery segment focuses on formulation development and manufacturing across a range of technologies, as well as integrated downstream clinical development and commercial supply solutions. The Clinical Supply Services segment offers manufacturing, packaging, storage, distribution, and inventory management for drugs, biologics, and clinical trials.
Catalent, Inc. is a major player in the stock market, with shares being actively traded. Investors closely monitor stocks share price today and premarket movements to make informed decisions. As a result, Catalent’s market cap can fluctuate based on changes in demand for its services, news related to the pharmaceutical industry, and other factors that impact the stock price.
Catalent Stock Price. Everything You Need To Know About The Catalent Stock! performance -
Employees
19000 -
Company HQ
Somerset -
Website
https://www.catalent.com/ -
CTLT Asset Type
Common Stock -
CTLT Market Capitalization
10.1B - Earnings Per Share -7.18
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth -0.154
Employees
19000Company HQ
SomersetWebsite
https://www.catalent.com/CTLT Asset Type
Common StockCTLT Market Capitalization
10.1BIf you are an investor from Malaysia, Thailand, Indonesia, or Vietnam looking to expand your portfolio, consider investing in Catalent. Catalent is a global leader in providing advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, and consumer health products. With a diverse range of services, including oral, injectable, and respiratory drug delivery, Catalent is well-positioned in the healthcare industry. To invest in Catalent from Malaysia, Thailand, Indonesia, or Vietnam, you can utilize the services offered by Zorion, an investment platform catering to retail investors in these regions. Zorion provides valuable investment insights and recommendations to help you make informed decisions. With Zorion, you can access resources and educational materials to enhance your investment knowledge and stay updated on the latest trends in the market. Investing in Catalent can offer you exposure to a reputable company with a strong presence in the pharmaceutical sector. With expert guidance from Zorion, you can confidently navigate the investment process and maximize your potential returns. Start investing in Catalent today through Zorion and seize the opportunities available in the stock market.
